Health Catalyst Capital

Health Catalyst Capital (HCC) is a private equity firm based in New York, specializing in investments within the healthcare information technology and tech-enabled services sectors. The firm focuses on the U.S. healthcare market, which exceeds $4 trillion in annual spending, aiming to enhance care quality, access, and affordability through technological solutions. HCC primarily targets the lower middle market, where its operational experience and industry expertise can drive significant growth and value creation.

The firm's investment strategy emphasizes sectors such as advanced and value-based care models, virtual care, consumer engagement, process automation, and data and AI enablement. HCC takes an active role in portfolio management, facilitating introductions to potential customers, appointing value-add board members, and supporting growth trajectories through continued funding. The firm also evaluates and executes merger opportunities to accelerate the scaling of its portfolio companies.

HCC's portfolio includes companies like Cylinder (formerly Vivante Health), Click Therapeutics, Glooko, Clearsense, Holmusk, Pager Health, Quarvis, Datavant, Vyne, Clareto, HealthMine, Insightin, MotionMSK, HiQOR, Quest Analytics, and ReferWell. These investments reflect HCC's commitment to partnering with innovative businesses that are poised to make a positive impact on the healthcare industry.